International Vaccine Institute on Covid vaccinations
[ad_1]
At Larry Flynt’s Hustler Club, Las Vegas, Nevada on December 21st 2021, a COVID-19 card holder was given a COVID-19 vaccine card.
Getty Images| Getty Images
A leading expert says that 2021 is the year of vaccine innovation. Accordingly to him, 2022 will mark the beginning of vaccinations and booster shots.
“2022 will be the year of vaccination — either primary for people who haven’t been vaccinated, or booster vaccinations for those of us who have,” said Jerome Kim, director general of the International Vaccine Institute, an independent non-profit devoted to research on vaccines for poor countries.
Kim said that it would be the year anti-Covid drugs are more prominent and will make treatment more efficient. Kim spoke on Monday to CNBC’s “Street Signs Asia”.
The U.S. Food and Drug Administration approved two emergency Covid-19 treatment pills in December. This was a significant milestone in the fight against coronavirus, which has claimed the lives of more than 5 million people around the world since its inception in 2019.
Pfizer’s Covid oral treatment pillPaxlovid was first antiviral medication to be approved for use as an emergency drug in the United States. Merck’s antiviral pill — known as molnupiravir — which was approved for use in adults with mild to moderate Covid at risk of severe disease.
The more transmissible Omicron variant was discovered as 2021 came to an end. Cases around the globe have increased in the last few weeks.
The week before, the caseload in the U.S. hit a record high. Johns Hopkins University’s data shows that the national average daily number of cases was over 265,000 per week as of Tuesday. The data revealed that it surpassed the Jan. 11, 2013 record of 252,000 daily average cases.
South Korea has announced that restrictions will be extended after the Asian Games in Seoul. a surge in serious Covid infections.
Giving vaccines to people who are in need
The key priority in 2022 is getting vaccines to people who need it — especially those in poorer countries who have limited access to them, Kim said.
“A really critical point to make — omicron is not the omega and we are going to see additional mutants and variants of concern, and hopefully we become more equitable in the use of vaccines,” he said.
Supply increases “Increasingly” [of vaccines]The issue will not arise. It will become a question of who is able to get the vaccine in the hands of those people who are most at risk. Kim explained that the “key to 2022 is getting people vaccinated.” Kim also said there is a significant number of low-income people who have not been vaccinated.
Our World in Data reports that 58.3% (or 58.3%) of the global population have had at least one dose. But only 8.5% in low-income countries have received at minimum one dose.
The ‘diagnostics gap must be closed’
Kim highlighted the so-called “diagnostics gaps” during Covid-19’s diagnosis phase.
He said that it meant lower-income countries don’t have as many tests, and therefore don’t perform as many sequencing. Coronavirus case samples can be used to help with genomic sequencing, which helps track the development of new variants.
He said that nations need to do more to address such divisions.
Kim stated that scientists can identify new variants by sequencing variants of all kinds from around the globe. Kim stated that it is crucial to address the issue as quickly and efficiently as possible in order for society to grow.
[ad_2]